Double Blind, Double Dummy, Cross-over Study to Compare the Bronchodilator Effect of CHF1535 pMDI (Fixed Combination of Beclometasone 50 microg + Formoterol 6 microg) Versus Free Combination of Beclometasone Plus Formoterol pMDI in Asthmatic Children

Trial Profile

Double Blind, Double Dummy, Cross-over Study to Compare the Bronchodilator Effect of CHF1535 pMDI (Fixed Combination of Beclometasone 50 microg + Formoterol 6 microg) Versus Free Combination of Beclometasone Plus Formoterol pMDI in Asthmatic Children

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Apr 2017

At a glance

  • Drugs Beclometasone/formoterol (Primary) ; Beclometasone; Formoterol
  • Indications Asthma
  • Focus Pharmacodynamics
  • Acronyms PAED3
  • Sponsors Chiesi
  • Most Recent Events

    • 21 Apr 2015 New source identified and integrated (European Clinical Trials Database record: EudraCT2011-002060-24)
    • 23 Nov 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 18 Jan 2013 Planned End Date changed from 1 Dec 2012 to 1 May 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top